Comparison of immulite with vidas for detection of infection in a low-prevalence population of pregnant women in The Netherlands.
A comparative evaluation of the Vidas system (bioMérieux, Marcy l'Etoile, France) and the Immulite System (Diagnostic Products Corporation) was performed using 500 prospectively collected serum samples. As part of a routine antenatal screening program, these samples were tested for hepatitis B surface antigen, and immunoglobulin G (IgG) and IgM antibodies to Toxoplasma gondii and rubella virus. The overall agreement between the two assay systems ranged from 98.0 to 99.8%. After discrepancy analysis the outcome in terms of relative sensitivity and specificity varied from 97.5 to 100%.
Vlaspolder
F
F
Laboratory for Medical Microbiology, Medical Center Alkmaar, The Netherlands. f.vlaspolder@mca.alkmaar.nl
Singer
P
P
Smit
A
A
Diepersloot
R J
RJ
D000818:Animals; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D007075:Immunoglobulin M / Q000276:immunology; D008403:Mass Screening / Q000379:methods*; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000175:diagnosis* / Q000276:immunology; D012680:Sensitivity and Specificity; D014122:Toxoplasma / Q000276:immunology / Q000302:isolation & purification*; D014125:Toxoplasmosis, Congenital / Q000276:immunology / Q000517:prevention & control*
D007074:Immunoglobulin G; D007075:Immunoglobulin M